Skip to main content
Kamada Ltd. logo

Kamada Ltd. — Investor Relations & Filings

Ticker · KMDA ISIN · IL0010941198 TA Manufacturing
Filings indexed 822 across all filing types
Latest filing 2014-09-04 Regulatory Filings
Country IL Israel
Listing TA KMDA

About Kamada Ltd.

https://www.kamada.com

Kamada Ltd. is a vertically integrated global biopharmaceutical company specializing in plasma-derived protein therapeutics. The company develops, manufactures, and commercializes a portfolio of products for rare and serious conditions, with a focus on therapeutic areas such as Alpha-1 Antitrypsin Deficiency (AATD) and Cytomegalovirus (CMV) prevention in transplant patients. Kamada utilizes a proprietary platform technology for advanced protein extraction and purification from human plasma. In addition to its marketed products, the company maintains a development pipeline of new therapies, including an inhaled treatment for AATD.

Recent filings

Filing Released Lang Actions
Immediate Report
Regulatory Filings Classification · 1% confidence The document is an 'Immediate Report' filed by KAMADA LTD, referencing the Israel Securities Authority and the Tel Aviv Stock Exchange. The key content states: 'Attached hereto is a report on *Kamada Reports Final Results from Phase 2/3 Clinical Trial of Inhaled Alpha-1 Antitrypsin to Treat Alpha-1 Antitrypsin Deficiency*'. This structure—a brief filing announcing the publication of a specific report (a clinical trial result announcement, which is often treated as a significant regulatory update or press release)—fits the description of a general regulatory announcement that doesn't map perfectly to the core financial reports (10-K, IR, ER). Given the short length (1684 chars) and the explicit mention of an attached PDF report, it aligns best with the 'Report Publication Announcement' (RPA) or the general 'Regulatory Filings' (RNS) category. Since the content is a specific, material update (clinical trial results), and not just announcing the release of a standard periodic report, RNS (Regulatory Filings) serves as the most appropriate general category for material, non-standard announcements, although RPA is also plausible if the attached PDF is the primary focus. However, RNS is the designated fallback for miscellaneous regulatory announcements. I will classify it as RNS as it is a specific regulatory disclosure that isn't a standard financial report or a management/board change.
2014-09-04 English
Other Report or Announcement
Regulatory Filings
2014-09-04 Hebrew (modern)
Other Report or Announcement
Report Publication Announcement Classification · 1% confidence The document is very short (1666 chars) and explicitly states that an announcement regarding clinical trial results is attached: "Attached hereto is a report on *Kamada to Announce Final Results from Phase 2/3 Clinical Trial of Inhaled AAT to Treat Alpha-1 Antitrypsin Deficiency on September 4, 2014*" and references a PDF file (*n_isa.pdf*). This structure—a brief notice stating that a substantive report is attached or published—fits the definition of a Report Publication Announcement (RPA) rather than the substantive report itself (like an ER or CT). It is an announcement about the publication of information.
2014-09-04 English
Other Report or Announcement
Regulatory Filings
2014-08-18 Hebrew (modern)
Other Report or Announcement
Interest Rate Update/Notice Classification · 1% confidence The document explicitly states it is an 'Other Report or Announcement' and the attached report title is: 'Kamada Ltd. Reports the Interest Rate for its Series C Debentures for the Period of June 1, 2014 to August 31, 2014'. This content directly relates to changes or notices regarding interest rates on financial instruments (debentures). This matches the definition for Interest Rate Update/Notice (IRAT). The document is short and serves as a notification of the attached report, but the core subject matter is specific enough to classify it directly rather than defaulting to RPA or RNS.
2014-08-18 English
Other Report or Announcement
Regulatory Filings
2014-08-14 Hebrew (modern)

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.